Why the study?
Does high hospital adherence to guideline-recommended therapies and safe antithrombotic dosing reduce in-hospital mortality and bleeding in patients with NSTE-ACS?
Observational (n=39,291)
Yes
Does high hospital adherence to guideline-recommended therapies and safe antithrombotic dosing reduce in-hospital mortality and bleeding in patients with NSTE-ACS?
Effect estimate: OR 0.80 (95% CI 0.67-0.94)
Hospital performance metrics that include both guideline adherence and appropriate antithrombotic dosing are independently associated with lower in-hospital mortality and bleeding in NSTE-ACS.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2015) conducted an observational in Non-ST-segment elevation acute coronary syndromes (n=39,291). Guideline adherence and antithrombotic dosing safety vs. Lower adherence and safety was evaluated on Risk-adjusted in-hospital mortality (OR 0.80, 95% CI 0.67-0.94).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: